B
Biomemory
Biotech & Life Sciences · Paris, France · Founded 2021
Provides biodigital data storage for large companies and administrations MoreLess
BioMemory is a groundbreaking startup that operates in the data storage industry, offering an innovative solution known as DNA Drives. The company has developed a unique technology that allows data to be stored on DNA, a medium that is not only ultra-durable but also environmentally friendly. This technology offers a storage density that is a million times higher than any Solid State Drive (SSD) or Magnetic Tape currently available in the market.
BioMemory's target clients are likely to be businesses and organizations that require long-term, secure, and high-density data storage solutions. This could range from tech companies to research institutions, and even government agencies. The company operates in the broader tech industry, but more specifically in the data storage and management market.
The business model of BioMemory revolves around the production and sale of its DNA Drives. The company generates revenue by selling these drives to clients who need to store large amounts of data in a secure and sustainable manner. The DNA Drives are assembled from bio-sourced components, which means they use less energy and have no CO2 emissions. This not only makes them a more sustainable choice but also a cost-effective one in the long run, as they require no energetic input and are stable at ambient temperatures.
In conclusion, BioMemory is a pioneering startup that is leveraging the power of DNA to revolutionize the data storage industry. It offers a solution that is not only more durable and efficient but also more environmentally friendly than traditional storage methods.
Keywords: BioMemory, DNA Drives, Data Storage, High-Density Storage, Sustainable Technology, Bio-Sourced Components, Long-Term Storage, Data Security, Tech Industry, Data Management.
Company overview
Biomemory company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2021
- Headquarters
- Paris, France
- Employees
- 78
- Open positions
- 6
- Dealroom signal
- 86.3
Valuation & funding
Biomemory funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2024 | $18M | $72M | Bpifrance · Paris Business Angels · Adnexus · Sorbonne Venture | ↗ |
| SUPPORT PROGRAM✓Other financing | Sep 2024 | $0 | — | CDL-Paris | — |
| SUPPORT PROGRAM✓Other financing | Sep 2023 | $0 | — | CDL-Paris | — |
| SEED✓Equity / VC | Nov 2022 | $5.5M | $22M | Prunay Impact · Paris Business Angels · EureKARE | ↗ |
| SUPPORT PROGRAM✓Other financing | Dec 2021 | $0 | — | CNRS Innovation | — |
| SUPPORT PROGRAMOther financing | Sep 2021 | Agoranov | ↗ | ||
| SPINOUT✓Other financing | Jun 2021 | SATT LUTECH · CNRS Innovation · Sorbonne University · French National Centre for Scientific Research - CNRS | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 80 |
| 2025 | 69 |
| 2024 | 47 |
| 2023 | 15 |
| 2022 | 9 |
| 2021 | 4 |
Growth signals
Biomemory website traffic
Latest recorded traffic for Biomemory is 2.3K monthly website visits, up 91.7% over the last three months. Biomemory's team grew 13% over the past year.
Hiring
Open positions at Biomemory
Current openings linked to this company in Dealroom.
Comparisons
Biomemory compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Biomemory's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Biomemory has talent and traffic
team presence
In the news
Latest news about Biomemory
Recent press, funding announcements, and product moves mentioning Biomemory — open to read from the original sources.
Market sentiment
What the market is saying about Biomemory
An AI-synthesized read of the highest-engagement posts about Biomemory on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biomemory’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.